Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Lead × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 EGFR-Mutant Lung Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Carboplatin 20 Cisplatin 15 Pemetrexed 14 pembrolizumab 13 Paclitaxel 13 Gemcitabine 8 osimertinib 6 durvalumab 6 Docetaxel 6 Nivolumab 5 Erlotinib Hydrochloride 4 130-nm albumin-bound paclitaxel 4 brigatinib 3 Gefitinib 3 vosaroxin 2 volociximab 2 pralsetinib 2 ensartinib 2 atezolizumab 2 anlotinib 2 aflibercept 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Ipilimumab 2 Drug Therapy 2 Cyclophosphamide 2 Cetuximab 2 Albumin-Bound Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00532155 2025-09-10

VITAL

Sanofi

Phase 3 Completed

913 enrolled 16 charts

Carcinoma, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡